FALLS CHURCH, Va. (PRWEB)
September 29, 2020

The CRC Trainer

An Interactive Companion to the CRC’s Guide to Coordinating Clinical Research

CenterWatch eLearning

https://www.centerwatch.com/products/472-the-crc-trainer

Wherever one falls on the spectrum of clinical research management, The CRC Trainer: An Interactive Companion to the CRC’s Guide to Coordinating Clinical Research provides the perfect interactive course to support learning the skills necessary for the role. Since book learning doesn’t work for all, it’s nice to have a self-paced, interactive option to evaluate how well one retains information.

The CRC’s Guide to Coordinating Clinical Research has long been looked at as the preeminent resource for training new CRCs and keeping experienced coordinators up-to-date on relevant changes in regulations. The detailed information in the guide covers everything a coordinator needs to know to succeed in the role — and The CRC Trainer: An Interactive Companion to the CRC’s Guide to Coordinating Clinical Research makes digesting that information simpler and straightforward.

This visual, interactive eLearning course was built to support learners in a self-paced journey through the complex material of the guide. It covers all essential aspects of the CRC role and focuses learners on the most important aspects of the guide.

During this eLearning course, we will cover:

• 
  The role and responsibilities of CRCs

     a. Qualities in an effective CRC

     b. Regulatory history and shifting rules

• The clinical research process

     a. Trial site quality systems

     b. Writing SOPs

     c. Research: from lab to trial to closeout

• Study preparation, protocols and reporting

     a. Site qualifications

     b. Working with vulnerable populations

     c. Ensuring data quality

• Trial participants, closures, monitoring and inspections

     a. Working with sponsors and monitors

     b. Storage of trial materials

     c. Working with IRBs and data safety monitoring boards

     d. Principles and challenges of informed consent

     e. Adverse event and safety monitoring

     f. Quality management and audits

The six modules of the course can be uploaded to a PC for use by individual trainees or added to an organization’s learning management system (LMS) to track and evaluate the progress of multiple trainees. A certificate of completion is awarded to trainees who pass the final exam.

This indispensable tool provides the skills and knowledge that are critical for managing clinical trials. Join other clinical trial professionals on the path to effective management.

Attendance at this program has been approved for a total of 3.00 contact hour of research specific continuing education on applications for Maintenance of ACRP’s CCRC®, CCRA®, CPI®, or ACRP-CP® certification designations.

Webinar Details:

The CRC Trainer:

An Interactive Companion to the CRC’s Guide to Coordinating Clinical Research

CenterWatch eLearning

https://www.centerwatch.com/products/472-the-crc-traine

eLearning Package:

Single User – $295

Multi-user buyers and licenses:

• 2-10 users – $275 per user
• 11-20 users – $255 per user
• 21-30 users – $235 per user
• 31-40 users – $215 per user
• 41-50 users – $200 per user
• 50+ users – Contact Bailey Sterrett at +1 703.538.7637 for LMS licensing prices.

Easy Ways to Register:

Online: https://www.centerwatch.com/products/472-the-crc-trainer

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email: